loading
Alpha Tau Medical Ltd stock is traded at $2.32, with a volume of 13,220. It is up +0.87% in the last 24 hours and up +2.20% over the past month. Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. The Alpha CaRT technology of the company utilizes the therapeutic properties of alpha particles aiming to overcome, and harness for benefit for alpha radiation's range. The company derives maximum revenue from Israel.
See More
Previous Close:
$2.30
Open:
$2.3
24h Volume:
13,220
Relative Volume:
0.60
Market Cap:
$159.14M
Revenue:
-
Net Income/Loss:
$-27.63M
P/E Ratio:
-7.25
EPS:
-0.32
Net Cash Flow:
$-39.43M
1W Performance:
+5.45%
1M Performance:
+2.20%
6M Performance:
-14.39%
1Y Performance:
-16.85%
1-Day Range:
Value
$2.27
$2.32
1-Week Range:
Value
$2.20
$2.32
52-Week Range:
Value
$1.75
$3.40

Alpha Tau Medical Ltd Stock (DRTS) Company Profile

Name
Name
Alpha Tau Medical Ltd
Name
Phone
-
Name
Address
-
Name
Employee
121
Name
Twitter
Name
Next Earnings Date
2023-05-23
Name
Latest SEC Filings
Name
DRTS's Discussions on Twitter

Compare DRTS with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
DRTS 2.295 159.14M 0 -27.63M -39.43M -0.32
VRTX 445.48 115.74B 10.63B -479.80M -1.35B 13.33
REGN 736.17 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 584.39 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 247.28 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 102.25 24.49B 3.30B -501.07M 1.03B 11.54

Alpha Tau Medical Ltd Stock (DRTS) Upgrades & Downgrades

Date Action Analyst Rating Change
Apr-14-22 Initiated Cantor Fitzgerald Overweight
Apr-08-22 Initiated Piper Sandler Overweight
Apr-04-22 Initiated Citigroup Buy

Alpha Tau Medical Ltd Stock (DRTS) Latest News

pulisher
Nov 20, 2024

Piper Sandler reaffirms OW rating on Alpha Tau Medical shares as 'multiple milestones' line up - Investing.com UK

Nov 20, 2024
pulisher
Nov 20, 2024

Alpha Tau Medical Announces Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire

Nov 20, 2024
pulisher
Nov 19, 2024

Alpha Tau Medical Advances in Cancer Treatment Technology - TipRanks

Nov 19, 2024
pulisher
Nov 19, 2024

Alpha Tau Medical Advances Cancer Treatment Pipeline, Reports $68.4M Cash Position | DRTS Stock News - StockTitan

Nov 19, 2024
pulisher
Nov 19, 2024

Alpha Emitter Market Size Expected to Hit USD 1751.5 Million by 2032, Expanding at a 11.25% CAGR: VMR - EIN News

Nov 19, 2024
pulisher
Nov 18, 2024

DRTSWAlpha Tau Medical Ltd. Warrant Latest Stock News & Market Updates - StockTitan

Nov 18, 2024
pulisher
Nov 15, 2024

Alpha Tau Medical Ltd. (NASDAQ:DRTS) Sees Significant Growth in Short Interest - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

Short Interest in Alpha Tau Medical Ltd. (NASDAQ:DRTS) Grows By 30.5% - Defense World

Nov 15, 2024
pulisher
Nov 13, 2024

Alpha Tau Medical to Showcase at Key Healthcare Conferences - TipRanks

Nov 13, 2024
pulisher
Nov 13, 2024

Alpha Tau to Participate in Citi's 2024 Global Healthcare Conference and Piper Sandler's 36th Annual Healthcare Conference - The Manila Times

Nov 13, 2024
pulisher
Nov 13, 2024

Alpha Tau to Participate in Citi’s 2024 Global Healthcare Conference and Piper Sandler’s 36th Annual Healthcare Conference - Marketscreener.com

Nov 13, 2024
pulisher
Nov 13, 2024

Alpha Tau to Participate in Citi’s 2024 Global Healthcare - GlobeNewswire

Nov 13, 2024
pulisher
Nov 13, 2024

Alpha Tau CFO to Present Alpha DaRT Cancer Therapy at Major Healthcare Conferences | DRTS Stock News - StockTitan

Nov 13, 2024
pulisher
Nov 12, 2024

Alpha Tau Medical to Hold Annual Shareholder Meeting - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

Alpha Tau Medical : Notice and proxy statement for the annual general meeting of shareholders of the Company to be held on December 17, 2024 Form 6 K - Marketscreener.com

Nov 12, 2024
pulisher
Nov 11, 2024

Medical Lasers Market Growth and Technology 2024 - openPR

Nov 11, 2024
pulisher
Nov 05, 2024

MasterCraft Boat Holdings, Inc. (NASDAQ:MCFT) Receives $19.20 Average Target Price from Analysts - Defense World

Nov 05, 2024
pulisher
Nov 05, 2024

Spire Global, Inc. (NYSE:SPIR) Receives $13.67 Average Target Price from Brokerages - Defense World

Nov 05, 2024
pulisher
Nov 05, 2024

Brinker International (NYSE:EAT) Sets New 52-Week High After Analyst Upgrade - Defense World

Nov 05, 2024
pulisher
Nov 05, 2024

Invesco Solar ETF Target of Unusually High Options Trading (NYSEARCA:TAN) - Defense World

Nov 05, 2024
pulisher
Nov 05, 2024

Traders Buy High Volume of Call Options on Nutrien (NYSE:NTR) - Defense World

Nov 05, 2024
pulisher
Nov 05, 2024

Brokerages Set Silvaco Group, Inc. (NASDAQ:SVCO) PT at $20.83 - Defense World

Nov 05, 2024
pulisher
Nov 05, 2024

Analysts Set Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) PT at $34.60 - Defense World

Nov 05, 2024
pulisher
Nov 05, 2024

Orthofix Medical (NASDAQ:OFIX) and Alpha Tau Medical (NASDAQ:DRTS) Financial Contrast - Defense World

Nov 05, 2024
pulisher
Nov 04, 2024

Top 230+ startups in Radiation Therapy Devices in Nov, 2024 - Tracxn

Nov 04, 2024
pulisher
Nov 04, 2024

Comparing Alpha Tau Medical (NASDAQ:DRTS) and Beyond Air (NASDAQ:XAIR) - Defense World

Nov 04, 2024
pulisher
Nov 01, 2024

Discover Alpha Tau Medical And 2 Other US Penny Stocks - Simply Wall St

Nov 01, 2024
pulisher
Oct 28, 2024

Head-To-Head Review: Biotricity (NASDAQ:BTCY) vs. Alpha Tau Medical (NASDAQ:DRTS) - Defense World

Oct 28, 2024
pulisher
Oct 23, 2024

HC Wainwright Reiterates "Buy" Rating for Alpha Tau Medical (NASDAQ:DRTS) - MarketBeat

Oct 23, 2024
pulisher
Oct 21, 2024

Alpha Tau Joins FDA Program to Advance Cancer Therapy - TipRanks

Oct 21, 2024
pulisher
Oct 21, 2024

Alpha Tau Announces Acceptance Into FDA's Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT® for Patients with Recurrent Glioblastoma Multiforme - The Manila Times

Oct 21, 2024
pulisher
Oct 21, 2024

Alpha Tau Announces Acceptance Into FDA’s Total Product - GlobeNewswire

Oct 21, 2024
pulisher
Oct 21, 2024

Alpha Tau Announces Acceptance Into FDA’s Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT® for Patients with Recurrent Glioblastoma Multiforme - Yahoo Finance

Oct 21, 2024
pulisher
Oct 18, 2024

Apple Inc (AAPL-Q) QuotePress Release - The Globe and Mail

Oct 18, 2024
pulisher
Oct 16, 2024

Alpha Tau Medical Ltd. (NASDAQ:DRTS) Short Interest Update - MarketBeat

Oct 16, 2024
pulisher
Oct 13, 2024

Alpha Tau Medical (NASDAQ:DRTS) Stock Rating Reaffirmed by HC Wainwright - Defense World

Oct 13, 2024
pulisher
Oct 12, 2024

Alpha Tau Medical shares maintain Buy rating from H.C. Wainwright By Investing.com - Investing.com Canada

Oct 12, 2024
pulisher
Oct 11, 2024

Alpha Tau’s Alpha DaRT Advances Lung Cancer Treatment - Yahoo Finance

Oct 11, 2024
pulisher
Oct 11, 2024

HC Wainwright Reaffirms "Buy" Rating for Alpha Tau Medical (NASDAQ:DRTS) - MarketBeat

Oct 11, 2024
pulisher
Oct 11, 2024

Alpha Tau Medical shares maintain Buy rating from H.C. Wainwright - Investing.com

Oct 11, 2024
pulisher
Oct 11, 2024

Alpha Emitter Market Size to witness nearly $1751.5 Million By 2032 - 대구포스트

Oct 11, 2024
pulisher
Oct 10, 2024

Alpha Tau treats first lung cancer patient with radiation therapy in Jerusalem - Mugglehead

Oct 10, 2024
pulisher
Oct 10, 2024

Alpha Tau Treats First Patient with Recurrent Lung Cancer - ForexTV.com

Oct 10, 2024
pulisher
Oct 10, 2024

Alpha Tau Medical Ltd. Treats First Patient with Recurrent Lung Cancer - Marketscreener.com

Oct 10, 2024
pulisher
Oct 04, 2024

Alpha Tau Appoints Industry Veteran Peter Melnyk as Chief Commercial Officer - Marketscreener.com

Oct 04, 2024
pulisher
Sep 30, 2024

Radiopharmaceutical Market 2024 – Industry Opportunities, Challenges, Value Chain and Sales Channels Analysis 2032 | Clarity Pharmaceuticals - 대구포스트

Sep 30, 2024
pulisher
Sep 30, 2024

Short Interest in Alpha Tau Medical Ltd. (NASDAQ:DRTS) Expands By 23.9% - MarketBeat

Sep 30, 2024
pulisher
Sep 26, 2024

Alpha Emitter Market Outlook, Key Trends and Growth Projections from 2024 to 2032 - 대구포스트

Sep 26, 2024
pulisher
Sep 26, 2024

Alpha Emitter Market on the Rise: A Study on its Growth Prospects - openPR

Sep 26, 2024
pulisher
Sep 26, 2024

Point72 DIFC Ltd Acquires Shares of 18,774 ChampionX Co. (NASDAQ:CHX) - Defense World

Sep 26, 2024
pulisher
Sep 23, 2024

Alpha Tau Medical Ltd.FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT in Immunocompromised Patients with Recurrent cSCC - Marketscreener.com

Sep 23, 2024

Alpha Tau Medical Ltd Stock (DRTS) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Cap:     |  Volume (24h):